Provider review
Live Vital review
By The Dose Brief Desk · Updated
Ten-week package totals are clearer than the site’s monthly labels; confirm product identity and renewal terms before comparing ongoing costs.
Not rated. This review examines published program information; it is not a firsthand treatment review.
At a glance
- Semaglutide
- $299 for a 10-week protocol
- Tirzepatide
- $549 for a 10-week protocol
- Availability
- Site advertises all 50 states; individual prescribing eligibility must be confirmed.
- Treatment formats
- Weekly injections advertised; brand versus compounded product not established by the reviewed pages.
Site also advertises $99/$183 monthly figures; ten weeks is not three calendar months. Renewal pricing unverified.
Start with the ten-week total
Live Vital’s semaglutide page pairs a $99 monthly headline with a $299 ten-week protocol. Its tirzepatide page pairs $183 with $549 for the same duration. Ten weeks is shorter than three calendar months, so the monthly labels are not a sound basis for comparing continuous treatment costs. The defensible comparison is the stated package total and ten-week supply.
A named clinician and an ongoing-care model
Both pages identify Dr. Patrick Taylor as the physician reviewing medical intake and tailoring treatment, and advertise unlimited care-team messaging. These are the provider’s descriptions of its service, not an independent verification of credentials or a firsthand report of responsiveness. Ask how follow-up occurs and who covers urgent medication questions between appointments.
Drug names do not confirm branded dispensing
The pages discuss Ozempic, Wegovy, Mounjaro and Zepbound while marketing semaglutide and tirzepatide protocols. Those references do not establish that a branded pen will be supplied. The pages describe preparation through a licensed U.S. pharmacy without identifying the pharmacy assigned to you. Obtain the exact prescription, manufacturer or compounder, concentration and packaging before paying; trial results for branded drugs do not establish results for an unspecified formulation.
What to establish beyond the introductory package
The reviewed treatment pages do not establish a continuing refill price or the refund calculation if treatment stops partway through the protocol. Ask whether the ten-week package covers every planned dose, whether it is charged in full, and what happens after week ten. Those answers determine whether this is a practical ongoing option rather than simply a low initial headline.
What stands out
- Specific ten-week package totals are published
- Names the reviewing physician and advertises messaging access
What to check
- Monthly labels do not match a three-calendar-month supply
- Dispensed product, future pricing and refunds need clarification
Sources and review scope
Public information checked in October 2026. Prices and eligibility can change. We have not enrolled in treatment, independently tested medications or verified the licenses of the clinicians and pharmacies involved in an individual prescription. Compounded medications are not FDA-approved; studies of approved brands do not establish that a compounded product has the same safety or effectiveness.